Actinogen Medical Limited (ATGGF)
OTCMKTS · Delayed Price · Currency is USD
0.0311
0.00 (0.00%)
Feb 4, 2026, 9:30 AM EST
Actinogen Medical Market Cap
Actinogen Medical has a market cap or net worth of $100.05 million as of February 5, 2026. Its market cap has increased by 103.99% in one year.
Market Cap
100.05M
Enterprise Value
90.82M
Revenue
3.60M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.03
Market Cap Chart
Since October 16, 2007, Actinogen Medical's market cap has increased from 11.50M to 100.05M, an increase of 770.06%. That is a compound annual growth rate of 12.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2026 | 107.04M | -17.45% |
| Dec 31, 2025 | 129.67M | 167.53% |
| Dec 31, 2024 | 48.47M | 40.08% |
| Dec 29, 2023 | 34.60M | -71.81% |
| Dec 30, 2022 | 122.77M | -40.54% |
| Dec 31, 2021 | 206.48M | 778.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CytoDyn | 308.99M |
| Silence Therapeutics | 228.61M |
| Vaxart | 154.67M |
| HST Global | 139.70M |
| BioStem Technologies | 109.20M |
| Nuo Therapeutics | 78.70M |
| Arch Biopartners | 53.28M |
| VitaSpring Biomedical | 51.78M |